{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:13:39Z","timestamp":1780452819912,"version":"3.54.1"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T00:00:00Z","timestamp":1566691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T00:00:00Z","timestamp":1566691200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1111\/bjd.18155","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T09:49:47Z","timestamp":1558604987000},"page":"287-299","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Monotherapy for toenail onychomycosis: a systematic review and network meta\u2010analysis"],"prefix":"10.1093","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8664-7723","authenticated-orcid":false,"given":"A.K.","family":"Gupta","sequence":"first","affiliation":[{"name":"Mediprobe Research Inc. London ON Canada"},{"name":"Division of Dermatology Department of Medicine University of Toronto School of Medicine Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.","family":"Foley","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc. London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.R.","family":"Mays","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc. London ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.H.","family":"Shear","sequence":"additional","affiliation":[{"name":"Division of Dermatology Department of Medicine University of Toronto School of Medicine Toronto ON Canada"},{"name":"Division of Dermatology Sunnybrook Health Sciences Centre Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Piguet","sequence":"additional","affiliation":[{"name":"Division of Dermatology Department of Medicine University of Toronto School of Medicine Toronto ON Canada"},{"name":"Division of Dermatology Women's College Hospital Toronto ON Canada"},{"name":"Division of Infection and Immunity Cardiff University School of Medicine Cardiff U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,8,25]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1972.01620050069017"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.12788\/j.sder.0014"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.104794"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.149.s65.4.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.12.019"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12323"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12873"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1997.00163.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1159\/000485632"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1875"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.06.005"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.331.7521.897"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200826090-00006"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1159\/000433473"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1037"},{"key":"e_1_2_6_18_1","unstructured":"U.S. Food and Drug Administration.FDA drug safety communication: FDA limits usage of Nizoral (ketoconazole) oral tablets due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems [internet]. Available at:https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm362415.htm. (last accessed 6 August 2018)."},{"key":"e_1_2_6_19_1","unstructured":"Health Canada.Health Canada endorsed important safety information on ketoconazole [internet]. Ketoconazole \u2013 risk of potentially fatal liver toxicity \u2013 for health professionals.2013. Available at:http:\/\/healthycanadians.gc.ca\/recall-alert-rappel-avis\/hc-sc\/2013\/34173a-eng.php. (last accessed 17 September 2014)."},{"key":"e_1_2_6_20_1","unstructured":"European Medicines Agency.European Medicines Agency recommends suspension of marketing authorisations for oral ketoconazole [internet]. 26 July 2013. Available at:http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2013\/07\/news_detail_001855.jsp&mid=WC0b01ac058004d5c1."},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2012.703308"},{"key":"e_1_2_6_22_1","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins JPT","year":"2011"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dss.2012.10.005"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.03.016"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13934"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1999.00713.x"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1996.tb15654.x"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70486-4"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/000155599750011020"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70111-7"},{"key":"e_1_2_6_31_1","first-page":"217","article-title":"Double\u2010blind, randomized comparison of itraconazole capsules vs. placebo in the treatment of toenail onychomycosis","volume":"59","author":"Elewski BE","year":"1997","journal-title":"Cutis"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.119674"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10660.x"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.10.013"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.04.010"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7190.1031"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.109071"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1159\/000051643"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.110874"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.03036.x"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1997.d01-1175.x"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2001.01204.x"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70492-X"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70490-6"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.00008.x"},{"key":"e_1_2_6_46_1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2340\/0001555555776669","article-title":"Oral terbinafine in toenail dermatophytosis. A double\u2010blind, placebo\u2010controlled multicenter study with 12 months\u2019 follow\u2010up","volume":"77","author":"Svejgaard EL","year":"1997","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)80057-0"},{"key":"e_1_2_6_48_1","first-page":"186","article-title":"Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double\u2010blind study","volume":"12","author":"Tschen EH","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.04.055"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)91815-9"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-017-0473-z"},{"key":"e_1_2_6_52_1","unstructured":"Sporanox\u00ae (itraconazole) capsules.Package insert 100 mg [internet]. Drugs@FDA: FDA approved drug products.2009. Available at:https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/020083s040s041s044lbl.pdf."},{"key":"e_1_2_6_53_1","unstructured":"Lamisil.Package insert: Lamisil (terbinafine hydrochloride) tablets 250 mg Drugs@FDA: FDA approved drug products 2012 [internet]. Available at:www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020539s021lbl.pdf."},{"key":"e_1_2_6_54_1","first-page":"626","article-title":"Onychomycosis: does cure equate to treatment success?","volume":"15","author":"Elewski BE","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_55_1","first-page":"25","article-title":"Treatment of onychomycosis with efinaconazole 10% topical solution and quality of life","volume":"7","author":"Tosti A","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/myc.12072"},{"key":"e_1_2_6_57_1","unstructured":"US Food and Drug Administration.Medical Devices and Clinical Trial Design for the Treatment or Improvement in the Appearance of Fungally\u2010Infected Nails. Guidance for Industry and Food and Drug Administration Staff [internet]. March 2016. Available at:http:\/\/www.fda.gov\/downloads\/MedicalDevices\/DeviceRegulationandGuidance\/GuidanceDocuments\/UCM431312.pdf."}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.18155","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.18155","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjd.18155","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.18155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T20:58:11Z","timestamp":1694897891000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/182\/2\/287\/6753169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,25]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.1111\/bjd.18155"],"URL":"https:\/\/doi.org\/10.1111\/bjd.18155","archive":["Portico"],"relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,25]]},"assertion":[{"value":"2019-05-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}